Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

VTGN ACTIVE INVESTIGATION: Lost Money on Vistagen Therapeutics, Inc.? Contact Levi & Korsinsky Now

accessnewswire.com
VTGN The article reports an investigation into Vistagen Therapeutics due to potential securities law violations following a failed clinical trial that caused an 81% stock price drop. This indicates significant negative news.

NEW YORK, NY / ACCESS Newswire / December 17, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation into Vistagen Therapeutics, Inc. ("Vistagen Therapeutics, Inc.") (NASDAQ:VTGN) concerning potential violations of the federal securities laws.

On December 17, 2025, before the market opened, Vistagen announced topline results from its PALISADE-3 Public Speaking Challenge Study of fasedienol for the acute treatment of social anxiety disorder (SAD).

The company reported that the study failed to meet its primary efficacy endpoint since it "did not demonstrate statistically significant improvement on primary endpoint of reduction in anxiety as measured by SUDS scores compared to placebo."

Following this news, VTGN's stock price fell over 81% to open at $0.88 per share.

If you suffered a loss on your Vistagen Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at [email protected] or call (212)363-7500 to speak to our team of experienced shareholder advocates.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (212)363-7500

Fax: (212)363-7171

SOURCE: Levi & Korsinsky, LLP